APA Alıntı

Kayabölen, A., Sahin, G. N., Seker, F., Cingöz, A., Isik, B., Acar, S., . . . Bagci-Onder, T. (2021). DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS. Neurooncol Adv.

Chicago Stili Alıntı

Kayabölen, Alişan, et al. "DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS." Neurooncol Adv 2021.

MLA Alıntı

Kayabölen, Alişan, et al. "DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS." Neurooncol Adv 2021.